2011
DOI: 10.2165/11206290-000000000-00000
|View full text |Cite
|
Sign up to set email alerts
|

Zoster vaccine (Zostavax®): a guide to its use in preventing herpes zoster and postherpetic neuralgia

&NA;
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…20,21 Zostavax ® (Sanofi Pasteur MSD) is a live attenuated VZV vaccine developed specifically for the prevention of HZ and PHN in individuals aged ≥ 50 y. 22 It has been shown to boost VZV-specific CMI. [23][24][25][26][27][28] The efficacy of HZ vaccine is highest…”
Section: Immunogenicity and Safety Of A Live Attenuated Shingles (Hermentioning
confidence: 99%
“…20,21 Zostavax ® (Sanofi Pasteur MSD) is a live attenuated VZV vaccine developed specifically for the prevention of HZ and PHN in individuals aged ≥ 50 y. 22 It has been shown to boost VZV-specific CMI. [23][24][25][26][27][28] The efficacy of HZ vaccine is highest…”
Section: Immunogenicity and Safety Of A Live Attenuated Shingles (Hermentioning
confidence: 99%